4.7 Article

Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Progression of basal ganglia pathology in heterozygousQ175knock-in Huntington's disease mice

Yunping Deng et al.

Summary: Using behavioral testing and morphological methods, we found that in male heterozygous Q175 mice, striatal neuron abnormalities and behavioral deficits begin to develop between 2 and 6 months of age, reflecting early effects of the HD mutation. While no significant loss of striatal neurons was observed at 18 months, there were signs of reduced expression and dendrite attenuation in certain neuron types as early as 6 months. Additionally, certain types of neurons, such as FoxP2+ arkypallidal GPe neurons and subthalamic nucleus neurons, were lost by 18 months but others, like prototypical PARV+ GPe neurons or dopaminergic nigral neurons, remained unaffected.

JOURNAL OF COMPARATIVE NEUROLOGY (2021)

Article Multidisciplinary Sciences

The mouse cortico-basal ganglia-thalamic network

Nicholas N. Foster et al.

Summary: The study reveals a complex structure in the brain, with 29 functional domains transmitting information through multiple channels, influencing cognition, sensorimotor behavior, and the development of various neurological and neuropsychiatric disorders.

NATURE (2021)

Review Neurosciences

Nanoscale synapse organization and dysfunction in neurodevelopmental disorders

Hanna L. Zieger et al.

Summary: Neurodevelopmental disorders may originate from genetic defects in synaptic proteins, disrupting the precise nanoscale organization of synapses and impacting synaptic function.

NEUROBIOLOGY OF DISEASE (2021)

Article Neurosciences

Striatal Direct Pathway Targets Npas1+ Pallidal Neurons

Qiaoling Cui et al.

Summary: The study reveals that direct-pathway striatal projection neurons not only innervate the external globus pallidus (GPe), but also selectively target Npas1(+) neurons within it. In a Parkinson's disease model, this projection is significantly strengthened, leading to movement suppression. This highlights the critical role of the direct-pathway striatal input to GPe as a circuit mechanism for regulating movement in both healthy and parkinsonian states.

JOURNAL OF NEUROSCIENCE (2021)

News Item Multidisciplinary Sciences

GENETIC THERAPIES FOR HUNTINGTON'S DISEASE FAIL IN CLINICAL TRIALS

Diana Kwon

NATURE (2021)

Article Cell Biology

Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington's disease mouse model

Hyun Jung Park et al.

Summary: Transplantation of human HLA homozygous induced pluripotent stem cell-derived neural precursor cells into HD mouse model showed significant improvement in motor and cognitive functions, along with multipotential differentiation and restoration of certain proteins and functions. These results strongly suggest the potential neuroprotection and functional recovery induced by iPSC-NPCs transplantation in HD patients, warranting further clinical trials.

CELL PROLIFERATION (2021)

Article Neurosciences

Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease

Justin L. Shobe et al.

Summary: Research suggests that impaired cortical and thalamic responses to reward stimuli, as well as impaired thalamocortical coherence, may play an important role in motor, cognitive, and learning deficits in Huntington's disease patients.

NEUROBIOLOGY OF DISEASE (2021)

Review Clinical Neurology

Deep brain stimulation in Huntington's disease: a literature review

Roberta Bonomo et al.

Summary: In patients with Huntington's disease, deep brain stimulation in the globus pallidus internus can lead to significant improvements in disease rating and motor symptoms, while effectively reducing chorea scores. Further studies are needed to identify reliable criteria to guide patient selection for DBS therapy.

NEUROLOGICAL SCIENCES (2021)

Review Cell Biology

Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders

Katherine L. Marshall et al.

Summary: Nervous system disorders are common health issues that will continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases, leading to axonal disconnection from targets and functional impairment. In some diseases, axons can regenerate or sprout in an attempt to reconnect with targets and restore synapse function.

NEURAL REGENERATION RESEARCH (2021)

Editorial Material Multidisciplinary Sciences

Antisense oligonucleotides for neurodegeneration

Blair R. Leavitt et al.

SCIENCE (2020)

Review Neurosciences

Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective

Anders Bjorklund et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Review Clinical Neurology

Therapeutic strategies for Huntington's disease

Carlos Estevez-Fraga et al.

CURRENT OPINION IN NEUROLOGY (2020)

Review Neurosciences

Cause or compensation?Altered neuronal Ca2+ handling in Huntington's disease

James P. Mackay et al.

CNS NEUROSCIENCE & THERAPEUTICS (2018)

Editorial Material Clinical Neurology

Seventy Years of Pallidotomy for Movement Disorders

Laura Cif et al.

MOVEMENT DISORDERS (2017)

Review Neurosciences

The external globus pallidus: progress and perspectives

Daniel J. Hegeman et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2016)

Article Neurosciences

The mouse cortico-striatal projectome

Houri Hintiryan et al.

NATURE NEUROSCIENCE (2016)

Review Neurosciences

The Biology of Huntingtin

Frederic Saudou et al.

NEURON (2016)

Article Multidisciplinary Sciences

Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease

Aldrin E. Molero et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Neurosciences

Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington's Disease

Asami Tanimura et al.

FRONTIERS IN SYSTEMS NEUROSCIENCE (2016)

Article Neurosciences

Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington's Disease

Alexander P. Osmand et al.

JOURNAL OF HUNTINGTONS DISEASE (2016)

Review Neurosciences

Corticostriatal synaptic adaptations in Huntington's disease

Joshua L. Plotkin et al.

CURRENT OPINION IN NEUROBIOLOGY (2015)

Article Clinical Neurology

Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels

Glenn M. Dallerac et al.

NEURODEGENERATIVE DISEASES (2015)

Article Behavioral Sciences

Mouse Models of Huntington's Disease

Simon P. Brooks et al.

BEHAVIORAL NEUROBIOLOGY OF HUNTINGTON'S DISEASE AND PARKINSON'S DISEASE (2015)

Article Clinical Neurology

Cortical Interneuron Loss and Symptom Heterogeneity in Huntington Disease

Eric H. Kim et al.

ANNALS OF NEUROLOGY (2014)

Article Biochemistry & Molecular Biology

A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease

Marianne R. Smith et al.

HUMAN MOLECULAR GENETICS (2014)

Article Neurosciences

Mutant Huntingtin Affects Cortical Progenitor Cell Division and Development of the Mouse Neocortex

Maria Molina-Calavita et al.

JOURNAL OF NEUROSCIENCE (2014)

Article Clinical Neurology

The pathophysiology and pharmacological treatment of Huntington disease

Connie Pidgeon et al.

BEHAVIOURAL NEUROLOGY (2013)

Article Neurosciences

Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's Disease

Veronique M. Andre et al.

JOURNAL OF NEUROSCIENCE (2011)

Article Neurosciences

Thalamic Contributions to Basal Ganglia-Related Behavioral Switching and Reinforcement

Yoland Smith et al.

JOURNAL OF NEUROSCIENCE (2011)

Article Neurosciences

Impaired dopamine release and uptake in R6/1 Huntington's disease model mice

Andrea N. Ortiz et al.

NEUROSCIENCE LETTERS (2011)

Article Clinical Neurology

Comparative EEG mapping studies in Huntington's disease patients and controls

Annamaria Painold et al.

JOURNAL OF NEURAL TRANSMISSION (2010)

Review Neurosciences

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

Giles E. Hardingham et al.

NATURE REVIEWS NEUROSCIENCE (2010)

Article Neurosciences

Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease

Damian M. Cummings et al.

JOURNAL OF NEUROSCIENCE (2009)

Review Clinical Neurology

Brain-derived neurotrophic factor in neurodegenerative diseases

Chiara Zuccato et al.

NATURE REVIEWS NEUROLOGY (2009)

Article Biochemistry & Molecular Biology

Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus

Simon C. Warby et al.

HUMAN MOLECULAR GENETICS (2008)

Article Clinical Neurology

Detection of Huntington's disease decades before diagnosis: the Predict-HD study

J. S. Paulsen et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)

Article Neurosciences

Altered information processing in the prefrontal cortex of Huntington's disease mouse models

Adam G. Walker et al.

JOURNAL OF NEUROSCIENCE (2008)

Article Neurosciences

Psychiatric symptoms in Huntington's disease before diagnosis: The Predict-HD study

Kevin Duff et al.

BIOLOGICAL PSYCHIATRY (2007)

Review Neurosciences

Re-emergence of striatal cholinergic interneurons in movement disorders

Antonio Pisani et al.

TRENDS IN NEUROSCIENCES (2007)

Article Neurosciences

Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease

Elizabeth H. Aylward

BRAIN RESEARCH BULLETIN (2007)

Review Clinical Neurology

Circuits and circuit disorders of the basal ganglia

Mahlon R. DeLong et al.

ARCHIVES OF NEUROLOGY (2007)

Article Biochemistry & Molecular Biology

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease

MA Johnson et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Clinical Neurology

Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study

SAJ Reading et al.

PSYCHIATRY RESEARCH-NEUROIMAGING (2005)

Article Pharmacology & Pharmacy

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery

C Zuccato et al.

PHARMACOLOGICAL RESEARCH (2005)

Review Biochemistry & Molecular Biology

Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study

YP Deng et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2004)

Article Biochemistry & Molecular Biology

The primate basal ganglia: parallel and integrative networks

SN Haber

JOURNAL OF CHEMICAL NEUROANATOMY (2003)

Article Biochemistry & Molecular Biology

Huntington's disease: a synaptopathy?

JY Li et al.

TRENDS IN MOLECULAR MEDICINE (2003)

Article Biochemistry & Molecular Biology

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease

EJ Slow et al.

HUMAN MOLECULAR GENETICS (2003)

Article Neurosciences

Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease

AJ Morton et al.

BRAIN RESEARCH BULLETIN (2001)

Article Multidisciplinary Sciences

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease

M Turmaine et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)